These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34786959)

  • 1. Routine Gadolinium Use for MRI Follow-Up of Multiple Sclerosis: Point-The Role of Leptomeningeal Enhancement.
    Okar SV; Reich DS
    AJR Am J Roentgenol; 2022 Jul; 219(1):24-25. PubMed ID: 34786959
    [No Abstract]   [Full Text] [Related]  

  • 2. Routine Gadolinium Use for MRI Follow-Up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.
    Rovira À; Auger C
    AJR Am J Roentgenol; 2022 Jul; 219(1):26-27. PubMed ID: 34786958
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis.
    Zivadinov R; Ramasamy DP; Hagemeier J; Kolb C; Bergsland N; Schweser F; Dwyer MG; Weinstock-Guttman B; Hojnacki D
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):642-647. PubMed ID: 29439125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of contrast-enhanced and non-contrast-enhanced MRI in the follow-up of multiple sclerosis.
    Zarei F; Ghaedian M; Ghaedian T
    Acta Radiol; 2021 Jul; 62(7):916-921. PubMed ID: 32762243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of Gadolinium in Follow-Up MRI of Multiple Sclerosis Patients: Current Recommendations].
    Cruz A; Pereira D; Batista S
    Acta Med Port; 2024 Jan; 37(1):53-63. PubMed ID: 38183232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of gadolinium-enhanced images on a follow-up magnetic resonance image in suspected multiple sclerosis.
    Moore FG; Levental M
    Can Assoc Radiol J; 2013 Nov; 64(4):358-62. PubMed ID: 23267520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Unenhanced and Gadolinium-Enhanced Imaging in Multiple Sclerosis: Is Contrast Needed for Routine Follow-Up MRI?
    Sadigh G; Saindane AM; Waldman AD; Lava NS; Hu R
    AJNR Am J Neuroradiol; 2019 Sep; 40(9):1476-1480. PubMed ID: 31439627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents.
    Gentili L; Capuano R; Gaetani L; Fiacca A; Bisecco A; d'Ambrosio A; Mancini A; Guercini G; Tedeschi G; Parnetti L; Gallo A; Di Filippo M
    J Neurol Sci; 2022 Nov; 442():120422. PubMed ID: 36162167
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic impact of selective use of contrast for routine follow-up MRI of patients with multiple sclerosis.
    Mattay RR; Davtyan K; Rudie JD; Mattay GS; Jacobs DA; Schindler M; Loevner LA; Schnall MD; Bilello M; Mamourian AC; Cook TS
    J Neuroimaging; 2022 Jul; 32(4):656-666. PubMed ID: 35294074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions.
    Brisset JC; Kremer S; Hannoun S; Bonneville F; Durand-Dubief F; Tourdias T; Barillot C; Guttmann C; Vukusic S; Dousset V; Cotton F;
    J Neuroradiol; 2020 Jun; 47(4):250-258. PubMed ID: 32014494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the Relevance of the Systematic Use of Gadolinium During the MRI Follow-Up of Multiple Sclerosis Patients Under Natalizumab?
    Bellanger G; Biotti D; Patsoura S; Ciron J; Ferrier M; Gramada R; Meluchova Z; Lerebours F; Catalaa I; Dumas H; Cognard C; Brassat D; Bonneville F
    Clin Neuroradiol; 2020 Sep; 30(3):553-558. PubMed ID: 31143968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Gadolinium-based Contrast Material Needed for MRI Follow-up of Multiple Sclerosis?
    Saindane AM
    Radiology; 2019 May; 291(2):436-437. PubMed ID: 30860449
    [No Abstract]   [Full Text] [Related]  

  • 13. Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
    Hildesheim FE; Ramasamy DP; Bergsland N; Jakimovski D; Dwyer MG; Hojnacki D; Lizarraga AA; Kolb C; Eckert S; Weinstock-Guttman B; Zivadinov R
    Mult Scler Relat Disord; 2021 Jan; 47():102653. PubMed ID: 33333417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.
    Wattjes MP; Ciccarelli O; Reich DS; Banwell B; de Stefano N; Enzinger C; Fazekas F; Filippi M; Frederiksen J; Gasperini C; Hacohen Y; Kappos L; Li DKB; Mankad K; Montalban X; Newsome SD; Oh J; Palace J; Rocca MA; Sastre-Garriga J; Tintoré M; Traboulsee A; Vrenken H; Yousry T; Barkhof F; Rovira À; ; ;
    Lancet Neurol; 2021 Aug; 20(8):653-670. PubMed ID: 34139157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pharmacological economic analysis of application of magnetic resonance contrast mediums containing gadolinium in case of multiple sclerosis].
    Shegay MM; Shimanovsky DN
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Mar; 29(2):343-346. PubMed ID: 33901380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New concepts about the role of magnetic resonance imaging in the diagnosis and follow-up of multiple sclerosis.
    Auger C; Rovira À
    Radiologia (Engl Ed); 2020; 62(5):349-359. PubMed ID: 32861433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent.
    Koch MW; Mostert J; Greenfield J; Liu WQ; Metz L
    J Neurol; 2020 Sep; 267(9):2619-2624. PubMed ID: 32388832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
    Aymerich FX; Auger C; Alcaide-Leon P; Pareto D; Huerga E; Corral JF; Mitjana R; Sastre-Garriga J; Montalban X; Rovira A
    Eur Radiol; 2017 Apr; 27(4):1361-1368. PubMed ID: 27456965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial gadolinium-enhanced magnetic resonance imaging in patients with multiple sclerosis treated with mitoxantrone.
    Krapf H; Mauch E; Fetzer U; Laufen H; Kornhuber HH
    Neuroradiology; 1995 Feb; 37(2):113-9. PubMed ID: 7760994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis.
    Miller DH; Barkhof F; Nauta JJ
    Brain; 1993 Oct; 116 ( Pt 5)():1077-94. PubMed ID: 8221048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.